Microenvironment-Simulated Cell Culture System for Tumor Modeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cell culture methods, such as two-dimensional and three-dimensional cell cultures, fail to accurately simulate the complex tumor microenvironment, leading to inconsistent drug screening results and high costs and time requirements for anticancer drug screening, especially in replicating oxygen gradients and immune cell distributions.

Innovation Solution

A microenvironment-simulated cell culture system comprising a cell culture chip with a long-stripped slot design, fluid delivery ports, and a fluid driving member, which creates a dynamic fluid circulation system to simulate the tumor microenvironment by establishing molecular gradients and replicating the interaction between tumors and the circulatory system, allowing for three-dimensional cell growth and extracellular matrix simulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If two-dimensional cell culture is used, then the culture method is simple, but it cannot represent the actual complexity of the tumor microenvironment

Engineering Contradiction:
Improvesimplicity of culture methodVSAvoidaccuracy of microenvironment simulation
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent transitions from two-dimensional cell culture to three-dimensional cell culture within a microfluidic device. The cell culture chamber provides a three-dimensional space for cell growth, allowing cells to form spheroids and interact with the extracellular matrix in a more physiologically relevant manner while maintaining the simplicity of in vitro culture systems.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If three-dimensional cell spheroid culture is used, then tissue characteristics in tumors can be simulated, but the gradient of oxygen, nutrient distribution and immune cell distribution are not easy to observe

Engineering Contradiction:
Improvesimulation of tissue characteristicsVSAvoidobservability of gradients and distributions
Core Design Contradiction:
ReliabilityVSDifficulty of detecting and measuring

Solution Approach 1:

The cell culture chamber is divided into multiple functional zones including a cell culture area, a fluid channel network, and observation regions. This segmentation allows different aspects of the tumor microenvironment to be studied in separate but interconnected compartments, enabling observation of oxygen gradients, nutrient distribution, and immune cell infiltration through transparent walls and controlled fluid flow paths.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces a microfluidic system as an intermediary that enables indirect observation and measurement of internal gradients. Fluid channels allow controlled delivery of nutrients and removal of waste, while transparent chamber walls facilitate optical monitoring of cell spheroids and their microenvironment without disrupting the three-dimensional structure.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If animal experiments are used for anticancer drug screening, then comprehensive in vivo data can be obtained, but the time and cost are extremely increased and reproducibility is reduced

Engineering Contradiction:
Improvecomprehensiveness of in vivo dataVSAvoidtime and cost efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent creates a simplified copy of the in vivo tumor microenvironment through a microfluidic device that replicates key physiological features including three-dimensional cell architecture, extracellular matrix composition, oxygen gradients, and immune cell interactions. This in vitro model provides comprehensive data comparable to animal experiments but with reduced time, cost, and improved reproducibility.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The system allows precise control and adjustment of critical parameters such as oxygen concentration, nutrient supply, pH levels, and cell density through the microfluidic network. This parameter control enables systematic study of tumor responses under different physiological conditions without the variability inherent in animal models.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This system effectively simulates the tumor microenvironment, reducing the time and cost of anticancer drug screening, enhancing reproducibility, and accurately representing the conditions of oxygen, nutrients, and immune cells, facilitating the screening of anticancer drugs for different types of cancer.

Implementation Method 1

a fluid driving member...which creates a dynamic fluid circulation system to simulate the tumor microenvironment

Methodology Applied
Scientific EffectFluid circulation: Convection

Implementation Method 2

establishing molecular gradients and replicating the interaction between tumors and the circulatory system

Methodology Applied
Scientific EffectMolecular gradients: Diffusion

Data Source

PatentUS20240002766A1Microenvironment-simulated cell culture system
Publication Date: 2024.01.04 FLUIDICONIC BIOTECHNOLOGY CO LTD
  • US20240002766A1 patent drawing
  • US20240002766A1 patent drawing
  • US20240002766A1 patent drawing

AI summary

A microenvironment-simulated cell culture system includes a cell culture chip, a fluid storage device and a fluid driving member. The cell culture chip includes a mainbody, a cell culture chamber, two fluid delivery ports and a sample loading well. The cell culture chamber is disposed in the mainbody and includes a first side portion and a second side portion. The two fluid delivery ports are separately disposed on the mainbody and respectively connected to the cell culture chamber. The sample loading well is disposed on the mainbody and connected to the cell culture chamber. The fluid storage device is pipe-connected to the cell culture chip. The fluid driving member is pipe-connected to the fluid storage device and the cell culture chip.